News & Tours
March 22, 2019

PGA Tour suspends Robert Garrigus three months after testing positive for marijuana


Michael Cohen

The PGA Tour announced a three-month suspension on Friday for Robert Garrigus following a failed drug test. Although the tour used the term "drug of abuse," Garrigus confirmed it was marijuana in a statement of his own.

Garrigus, who overcame drug and alcohol abuse to become a PGA Tour winner in 2010 and finish T-3 at the 2011 U.S. Open, hasn't played since missing the cut at last month's Puerto Rico Open. His best finish during the 2018-'19 season was a T-20 at the Sanderson Farms Championship in October.

Garrigus is the first PGA Tour pro to be suspended—at least, publicly—for a "drug of abuse," which the tour defines in its anti-doping manual as "recreational drugs that are often times obtained illegally." Here was the full statement from the PGA Tour:

The PGA Tour announced today that Robert Garrigus has violated the PGA Tour Anti-Doping Program by testing positive for a substance identified as a drug of abuse. In accordance with the PGA Tour Conduct Policy that applies to violations involving drugs of abuse, he has been suspended for a period of three months.

And here's the statement from Garrigus, which was issued at the same time to complete this well-coordinated Friday afternoon announcement:

Garrigus joins a handful of players to be publicly suspended for violating the PGA Tour anti-doping program. Most notably, Vijay Singh was given a three-month suspension in 2013 for admitting to using a banned substance, but wound up having his punishment rescinded. Singh then sued the tour for its handling of his case and eventually settled out of court in November.

You are using an unsupported version of Internet Explorer. Please upgrade to Internet Explorer 11 or use a different web browser.